UNIVEC is focused on targeting it's products for special diseases such as Sickle Cell Anemia, cancer, HIV/Aids, Hepatitis C. Multiple Sclerosis, Hemophilia and Drug Addiction. UNIVEC combines a targeted mix of production and sales to maintain a strong national market. UNIVEC has formed affiliate agreements with major pharmaceutical firms for production and distribution efficiency. This strategy allows the company the option to form relationships with a number of specialized partners. This also allows UNIVEC to be more cost effective because it will not need a large sales force nor a large marketing budget. Specialty Pharmaceutical are high cost products that are not usually dispensed in retail pharmacies. They are products that require special handling and oversight.
Physician and Pharmaceutical services Inc. (PPSI) is an wholly owned subsidiary of UNIVEC that provides pharmaceutical samples to physicians and patients through it "StarterScript" system. This system provides the physician a voucher or co-payment card to give to the patient instead of the drug products. The patient takes the "StarterScript" to 50,000 plus retail pharmacies that are on the PPSI real-time processing system for dispensing and drug interaction monitoring. PPSI sample distribution systems is for pharmaceutical companies nationwide. PPSI is also a medication therapy management ( MTM ) company that provides support for medications management ,compliance, and drug interactions solutions.
UNIVEC is a Minority Business Enterprise(MBE) certified by the state of New York.